Cargando…

New concepts in anti-HIV therapies

Detalles Bibliográficos
Autores principales:	Stebbing, Justin, Bower, Mark, Gazzard, Brian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2006
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115033/ http://dx.doi.org/10.1007/978-0-387-31047-3_7

Ejemplares similares

Outcome of patients with HIV-related germ cell tumours: a case–control study
por: Powles, T, et al.
Publicado: (2004)

30 years of HIV: what have we learned?
por: Gazzard, Brian
Publicado: (2014)

New strategies for lowering the costs of antiretroviral treatment and care for people with HIV/AIDS in the United Kingdom
por: Gazzard, Brian, et al.
Publicado: (2012)

HIV-associated primary lung cancer (LC) in the era of highly active antiretroviral therapy (HAART): a multi-institutional collaboration
por: D’Jaen, Gabriela, et al.
Publicado: (2010)

Does HIV adversely influence the outcome in advanced non-small-cell lung cancer in the era of HAART?
por: Powles, T, et al.
Publicado: (2003)

Gastrointestinal manifestations of HIV infection
por: Sharpstone, D, et al.
Publicado: (1996)

Breast Cancer in the Setting of HIV
por: Palan, Mitul, et al.
Publicado: (2011)

Opportunistic Infections in HIV Seropositive Individuals: CME Lecture
por: Gazzard, B G
Publicado: (1995)

Maintaining cost-effective access to antiretroviral drug therapy through a collaborative approach to drug procurement, consensus treatment guidelines and regular audit: the experience of London HIV commissioners and providers
por: Foreman, Claire, et al.
Publicado: (2012)

Are Long-Term Non-Progressors Very Slow Progressors? Insights from the Chelsea and Westminster HIV Cohort, 1988–2010
por: Mandalia, Sundhiya, et al.
Publicado: (2012)

Prevention of atherosclerosis in patients living with HIV
por: De Lorenzo, Ferruccio, et al.
Publicado: (2009)

CNS penetration of potential anti-COVID-19 drugs
por: Richardson, Peter J., et al.
Publicado: (2020)

Endocrine Resistance in Hormone Receptor Positive Breast Cancer–From Mechanism to Therapy
por: Rani, Aradhana, et al.
Publicado: (2019)

The pharmacokinetics of high-dose methotrexate in people living with HIV on antiretroviral therapy
por: Dalla Pria, Alessia, et al.
Publicado: (2015)

HIV-associated anal cancer
por: Newsom-Davis, Thomas, et al.
Publicado: (2010)

COVID-19: combining antiviral and anti-inflammatory treatments
por: Stebbing, Justin, et al.
Publicado: (2020)

Transient Nature of Long-Term Nonprogression and Broad Virus-Specific Proliferative T-Cell Responses with Sustained Thymic Output in HIV-1 Controllers
por: Westrop, Samantha J., et al.
Publicado: (2009)

Anti-EGFR-Targeted Therapy for Esophageal and Gastric Cancers: An Evolving Concept
por: Dragovich, Tomislav, et al.
Publicado: (2009)

HIV Associated Neurocognitive Disorders Subsidence Through Citalopram Addition in Anti-retroviral Therapy (HANDS-CARE): A Concept Note
por: Ojagbemi, Akin
Publicado: (2021)

New Concepts in Pacemaker Syndrome
por: Farmer, D. Michael, et al.
Publicado: (2004)

Treatment and Prophylaxis of Pneumocystis carinii Pneumonia in AIDS Patients
por: Smith, Don, et al.
Publicado: (2012)

Nevirapine and Efavirenz Elicit Different Changes in Lipid Profiles in Antiretroviral- Therapy-Naive Patients Infected with HIV-1
por: van Leth, Frank, et al.
Publicado: (2004)

New and emerging concepts and therapies for the treatment of food allergy
por: Hwang, David W, et al.
Publicado: (2022)

Mycobacterial immune reconstitution inflammatory syndrome in HIV-1 infection after antiretroviral therapy is associated with deregulated specific T-cell responses: Beneficial effect of IL-2 and GM-CSF immunotherapy
por: Pires, A, et al.
Publicado: (2005)

Universal access to anti-HIV therapy
por: Souteyrand, Yves
Publicado: (2012)

The biology of HIV-associated lymphomas.
por: Bower, M.
Publicado: (1992)

Deep sequencing of small RNAs identifies canonical and non-canonical miRNA and endogenous siRNAs in mammalian somatic tissues
por: Castellano, Leandro, et al.
Publicado: (2013)

What Is the Best Drug to Treat COVID-19? The Need for Randomized Controlled Trials
por: Ottaviani, Silvia, et al.
Publicado: (2020)

Reducing transmission of SARS-CoV-2 with intranasal prophylaxis
por: Boiardi, Federico, et al.
Publicado: (2020)

Developments in paediatric cancer care throughout the COVID-19 pandemic: Lessons from China
por: Boiardi, Federico, et al.
Publicado: (2022)

What is the intermediate host species of SARS-CoV-2?
por: Friend, Thomas, et al.
Publicado: (2021)

The promise of the anti-idiotype concept
por: Kieber-Emmons, Thomas, et al.
Publicado: (2012)

Criticality of Timing for Anti-HIV Therapy Initiation
por: Castiglione, Filippo, et al.
Publicado: (2010)

Proof-of-concept study of an at-home, engaging, digital intervention for pediatric ADHD
por: Davis, Naomi O., et al.
Publicado: (2018)

Dual Mechanisms of Action of Self-Delivering, Anti-HIV-1 FANA Oligonucleotides as a Potential New Approach to HIV Therapy
por: Takahashi, Mayumi, et al.
Publicado: (2019)

A new concept for cancer therapy: out-competing the aggressor
por: Deisboeck, Thomas S, et al.
Publicado: (2008)

HIV-AIDS prevention in the conception of HIV-positive young people
por: Taquette, Stella Regina, et al.
Publicado: (2019)

The Efficacy of Lapatinib in Metastatic Breast Cancer with HER2 Non-Amplified Primary Tumors and EGFR Positive Circulating Tumor Cells: A Proof-Of-Concept Study
por: Stebbing, Justin, et al.
Publicado: (2013)

Managing patients with cancer in the COVID-19 era
por: Peng, Ling, et al.
Publicado: (2020)

Baricitinib: the first immunomodulatory treatment to reduce COVID-19 mortality in a placebo-controlled trial
por: Kalil, Andre C, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kmfudk14hlr0nboj3ftja54kdr